163:
29:
432:
339:
Zhou, Jin; Waskowicz, Lauren R.; Lim, Andrea; Liao, Xiao-Hui; Lian, Brian; Masamune, Hiroko; Refetoff, Samuel; Tran, Brian; Koeberl, Dwight D.; Yen, Paul M. (1 August 2019).
402:
300:"Thyromimetics as emerging therapeutic agents for nonalcoholic steatohepatitis: rationale for the development of resmetirom (MGL-3196)"
422:
253:
57:
427:
412:
249:
122:
142:
273:
245:
341:"A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia"
158:
82:
407:
378:
360:
321:
417:
368:
352:
311:
179:
91:
241:
131:
162:
373:
340:
73:)-4-(3-Chlorophenyl)-2-methyl}-3,5-dimethylphenoxy)methyl]-1,3,2λ-dioxaphosphinan-2-one
396:
234:
316:
299:
212:
364:
325:
382:
356:
102:
111:
237:
20:
433:
Experimental drugs developed for non-alcoholic fatty liver disease
28:
147:
211:
178:
173:
141:
121:
101:
81:
48:
40:
35:
90:
8:
19:
161:
27:
372:
315:
248:in a phase II trial for the treatment of
130:
304:Expert Opinion on Investigational Drugs
265:
240:whose active form is selective for the
157:
110:
62:
403:Thyroid hormone receptor beta agonists
18:
7:
252:and is also being investigated for
298:Alkhouri, Naim (1 February 2020).
244:isoform. It is being developed by
205:
14:
254:glycogen storage disease type Ia
196:
190:
199:
184:
1:
317:10.1080/13543784.2020.1708899
250:nonalcoholic steatohepatitis
449:
174:Chemical and physical data
53:
26:
423:3-Chlorophenyl compounds
357:10.1089/thy.2019.0007
428:Isopropyl compounds
413:Dioxaphosphorinanes
278:Viking Therapeutics
246:Viking Therapeutics
229:(formerly known as
23:
224:
223:
143:CompTox Dashboard
16:Chemical compound
440:
387:
386:
376:
351:(8): 1158–1167.
336:
330:
329:
319:
295:
289:
288:
286:
284:
270:
219:
207:
201:
198:
192:
186:
166:
165:
151:
149:
134:
114:
94:
44:VK-2809; MB07811
31:
24:
22:
448:
447:
443:
442:
441:
439:
438:
437:
393:
392:
391:
390:
338:
337:
333:
297:
296:
292:
282:
280:
272:
271:
267:
262:
217:
204:
195:
189:
169:
159:DTXSID501005783
145:
137:
117:
97:
77:
74:
61:
60:
17:
12:
11:
5:
446:
444:
436:
435:
430:
425:
420:
415:
410:
405:
395:
394:
389:
388:
331:
290:
264:
263:
261:
258:
222:
221:
215:
209:
208:
202:
193:
187:
182:
176:
175:
171:
170:
168:
167:
154:
152:
139:
138:
136:
135:
127:
125:
119:
118:
116:
115:
107:
105:
99:
98:
96:
95:
87:
85:
79:
78:
76:
75:
64:
56:
55:
54:
51:
50:
46:
45:
42:
38:
37:
33:
32:
15:
13:
10:
9:
6:
4:
3:
2:
445:
434:
431:
429:
426:
424:
421:
419:
416:
414:
411:
409:
406:
404:
401:
400:
398:
384:
380:
375:
370:
366:
362:
358:
354:
350:
346:
342:
335:
332:
327:
323:
318:
313:
310:(2): 99–101.
309:
305:
301:
294:
291:
279:
275:
269:
266:
259:
257:
255:
251:
247:
243:
239:
236:
232:
228:
216:
214:
210:
183:
181:
177:
172:
164:
160:
156:
155:
153:
144:
140:
133:
129:
128:
126:
124:
120:
113:
109:
108:
106:
104:
100:
93:
89:
88:
86:
84:
80:
72:
68:
63:
59:
52:
47:
43:
39:
36:Clinical data
34:
30:
25:
348:
344:
334:
307:
303:
293:
283:15 September
281:. Retrieved
277:
268:
235:thyromimetic
230:
226:
225:
70:
66:
220: g·mol
92:852948-13-1
49:Identifiers
41:Other names
397:Categories
260:References
213:Molar mass
132:3Z11398FNQ
83:CAS Number
58:IUPAC name
365:1050-7256
326:1354-3784
408:Prodrugs
383:31337282
274:"VK2809"
103:DrugBank
418:Phenols
374:6707038
345:Thyroid
238:prodrug
233:) is a
231:MB07811
180:Formula
112:DB15137
381:
371:
363:
324:
227:VK2809
218:514.98
21:VK2809
242:THR-β
379:PMID
361:ISSN
322:ISSN
285:2023
123:UNII
369:PMC
353:doi
312:doi
148:EPA
399::
377:.
367:.
359:.
349:29
347:.
343:.
320:.
308:29
306:.
302:.
276:.
256:.
197:Cl
194:32
188:28
69:,4
65:(2
385:.
355::
328:.
314::
287:.
206:P
203:5
200:O
191:H
185:C
150:)
146:(
71:S
67:R
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
